- This record was updated by the submitter. Please see the current version.
NM_001148.6(ANK2):c.155A>G (p.Lys52Arg) AND Long QT syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jun 17, 2023
- Review status:
- 1 star out of maximum of 4 starscriteria provided, single submitter
- Somatic classification
of clinical impact: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Somatic classification
of oncogenicity: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Record status:
- current
- Accession:
- RCV003840398.1
Allele description
NM_001148.6(ANK2):c.155A>G (p.Lys52Arg)
- Gene:
- ANK2:ankyrin 2 [Gene - OMIM - HGNC]
- Variant type:
- single nucleotide variant
- Cytogenetic location:
- 4q25
- Genomic location:
- Preferred name:
- NM_001148.6(ANK2):c.155A>G (p.Lys52Arg)
- HGVS:
- NC_000004.12:g.113174486A>G
- NG_009006.2:g.361404A>G
- NM_001127493.3:c.92A>G
- NM_001148.6:c.155A>GMANE SELECT
- NM_001354225.2:c.155A>G
- NM_001354228.2:c.155A>G
- NM_001354230.2:c.200A>G
- NM_001354231.2:c.200A>G
- NM_001354232.2:c.155A>G
- NM_001354235.2:c.155A>G
- NM_001354236.2:c.155A>G
- NM_001354237.2:c.200A>G
- NM_001354239.2:c.92A>G
- NM_001354240.2:c.200A>G
- NM_001354241.2:c.200A>G
- NM_001354242.2:c.200A>G
- NM_001354243.2:c.92A>G
- NM_001354244.2:c.92A>G
- NM_001354245.2:c.155A>G
- NM_001354246.2:c.155A>G
- NM_001354249.2:c.92A>G
- NM_001354252.2:c.92A>G
- NM_001354253.2:c.92A>G
- NM_001354254.2:c.92A>G
- NM_001354255.2:c.92A>G
- NM_001354256.2:c.92A>G
- NM_001354257.2:c.92A>G
- NM_001354258.2:c.155A>G
- NM_001354260.2:c.92A>G
- NM_001354261.2:c.137A>G
- NM_001354262.2:c.92A>G
- NM_001354264.2:c.92A>G
- NM_001354265.2:c.155A>G
- NM_001354266.2:c.92A>G
- NM_001354267.2:c.92A>G
- NM_001354268.2:c.155A>G
- NM_001354269.3:c.143A>G
- NM_001354270.2:c.92A>G
- NM_001354271.2:c.92A>G
- NM_001354272.2:c.92A>G
- NM_001354273.2:c.155A>G
- NM_001354274.2:c.92A>G
- NM_001354275.2:c.92A>G
- NM_001354276.2:c.92A>G
- NM_001354277.2:c.92A>G
- NM_001386142.1:c.92A>G
- NM_001386143.1:c.92A>G
- NM_001386144.1:c.200A>G
- NM_001386146.1:c.92A>G
- NM_001386147.1:c.137A>G
- NM_001386148.2:c.143A>G
- NM_001386149.1:c.92A>G
- NM_001386150.1:c.92A>G
- NM_001386151.1:c.92A>G
- NM_001386152.1:c.200A>G
- NM_001386153.1:c.92A>G
- NM_001386154.1:c.92A>G
- NM_001386156.1:c.92A>G
- NM_001386157.1:c.92A>G
- NM_001386158.1:c.92A>G
- NM_001386160.1:c.137A>G
- NM_001386161.1:c.92A>G
- NM_001386162.1:c.92A>G
- NM_001386174.1:c.206A>G
- NM_001386175.1:c.206A>G
- NM_001386186.2:c.143A>G
- NM_001386187.2:c.143A>G
- NM_020977.5:c.155A>G
- NP_001120965.1:p.Lys31Arg
- NP_001120965.1:p.Lys31Arg
- NP_001139.3:p.Lys52Arg
- NP_001139.3:p.Lys52Arg
- NP_001341154.1:p.Lys52Arg
- NP_001341157.1:p.Lys52Arg
- NP_001341159.1:p.Lys67Arg
- NP_001341160.1:p.Lys67Arg
- NP_001341161.1:p.Lys52Arg
- NP_001341164.1:p.Lys52Arg
- NP_001341165.1:p.Lys52Arg
- NP_001341166.1:p.Lys67Arg
- NP_001341168.1:p.Lys31Arg
- NP_001341169.1:p.Lys67Arg
- NP_001341170.1:p.Lys67Arg
- NP_001341171.1:p.Lys67Arg
- NP_001341172.1:p.Lys31Arg
- NP_001341173.1:p.Lys31Arg
- NP_001341174.1:p.Lys52Arg
- NP_001341175.1:p.Lys52Arg
- NP_001341178.1:p.Lys31Arg
- NP_001341181.1:p.Lys31Arg
- NP_001341182.1:p.Lys31Arg
- NP_001341183.1:p.Lys31Arg
- NP_001341184.1:p.Lys31Arg
- NP_001341185.1:p.Lys31Arg
- NP_001341186.1:p.Lys31Arg
- NP_001341187.1:p.Lys52Arg
- NP_001341189.1:p.Lys31Arg
- NP_001341190.1:p.Lys46Arg
- NP_001341191.1:p.Lys31Arg
- NP_001341193.1:p.Lys31Arg
- NP_001341194.1:p.Lys52Arg
- NP_001341195.1:p.Lys31Arg
- NP_001341196.1:p.Lys31Arg
- NP_001341197.1:p.Lys52Arg
- NP_001341198.1:p.Lys48Arg
- NP_001341199.1:p.Lys31Arg
- NP_001341200.1:p.Lys31Arg
- NP_001341201.1:p.Lys31Arg
- NP_001341202.1:p.Lys52Arg
- NP_001341203.1:p.Lys31Arg
- NP_001341204.1:p.Lys31Arg
- NP_001341205.1:p.Lys31Arg
- NP_001341206.1:p.Lys31Arg
- NP_001373071.1:p.Lys31Arg
- NP_001373072.1:p.Lys31Arg
- NP_001373073.1:p.Lys67Arg
- NP_001373075.1:p.Lys31Arg
- NP_001373076.1:p.Lys46Arg
- NP_001373077.1:p.Lys48Arg
- NP_001373078.1:p.Lys31Arg
- NP_001373079.1:p.Lys31Arg
- NP_001373080.1:p.Lys31Arg
- NP_001373081.1:p.Lys67Arg
- NP_001373082.1:p.Lys31Arg
- NP_001373083.1:p.Lys31Arg
- NP_001373085.1:p.Lys31Arg
- NP_001373086.1:p.Lys31Arg
- NP_001373087.1:p.Lys31Arg
- NP_001373089.1:p.Lys46Arg
- NP_001373090.1:p.Lys31Arg
- NP_001373091.1:p.Lys31Arg
- NP_001373103.1:p.Lys69Arg
- NP_001373104.1:p.Lys69Arg
- NP_001373115.1:p.Lys48Arg
- NP_001373116.1:p.Lys48Arg
- NP_066187.2:p.Lys52Arg
- LRG_327t1:c.155A>G
- LRG_327t2:c.92A>G
- LRG_327:g.361404A>G
- LRG_327p1:p.Lys52Arg
- LRG_327p2:p.Lys31Arg
- NC_000004.11:g.114095642A>G
- NM_001127493.1:c.92A>G
- NM_001148.4:c.155A>G
This HGVS expression did not pass validation- Protein change:
- K31R
- Molecular consequence:
- NM_001127493.3:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001148.6:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354225.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354228.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354230.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354231.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354232.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354235.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354236.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354237.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354239.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354240.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354241.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354242.2:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354243.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354244.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354245.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354246.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354249.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354252.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354253.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354254.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354255.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354256.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354257.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354258.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354260.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354261.2:c.137A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354262.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354264.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354265.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354266.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354267.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354268.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354269.3:c.143A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354270.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354271.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354272.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354273.2:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354274.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354275.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354276.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001354277.2:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386142.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386143.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386144.1:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386146.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386147.1:c.137A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386148.2:c.143A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386149.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386150.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386151.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386152.1:c.200A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386153.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386154.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386156.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386157.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386158.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386160.1:c.137A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386161.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386162.1:c.92A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386174.1:c.206A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386175.1:c.206A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386186.2:c.143A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001386187.2:c.143A>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_020977.5:c.155A>G - missense variant - [Sequence Ontology: SO:0001583]
Condition(s)
- Name:
- Long QT syndrome (LQTS)
- Identifiers:
- MONDO: MONDO:0002442; MeSH: D008133; MedGen: C0023976
Assertion and evidence details
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV004641497 | Invitae | criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) | Uncertain significance (Jun 17, 2023) | germline | clinical testing |
Summary from all submissions
Ethnicity | Origin | Affected | Individuals | Families | Chromosomes tested | Number Tested | Family history | Method |
---|---|---|---|---|---|---|---|---|
not provided | germline | unknown | not provided | not provided | not provided | not provided | not provided | clinical testing |
Citations
PubMed
Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.
Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.
- PMID:
- 28492532
- PMCID:
- PMC5632818
Details of each submission
From Invitae, SCV004641497.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
Description
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ANK2 protein function. This variant has not been reported in the literature in individuals affected with ANK2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 52 of the ANK2 protein (p.Lys52Arg).
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
Last Updated: Mar 5, 2024